Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11952364
TRK inhibitors useful as anticancer drugs
granted -
US 11952389
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11951100
Formulations of RBP4 inhibitors and methods of use
granted -
US 11952352
Ras inhibitors
granted -
US 11952376
Substituted amino acids as integrin inhibitors
granted -
US 11944614
Imidazo[4,5-c]pyridine compounds as LSD-1 inhibitors
granted -
US 11944626
Small molecule inhibitors of ALDH and uses thereof
granted -
US 11939361
Compositions of peptide inhibitors of Interleukin-23 receptor
granted -
US 11939340
CDK inhibitors and their use as pharmaceuticals
granted -
US 11931402
Compositions for treating heart disease by inhibiting the action of mAKAP-β
granted -
US 11931343
CD73 inhibitors
granted -
US 11932633
KRas G12C inhibitors
granted -
US 11925629
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 11919888
Neprilysin inhibitors
granted -
US 11919901
Inhibitors of the menin-MLL interaction
granted -
US 11919880
HCV protease inhibitors
granted -
US 11912695
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11905285
Inhibitors of plasma kallikrein and uses thereof
granted -
US 11897845
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 11891607
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
granted -
US 11891399
Inhibitors of cancer invasion, attachment, and/or metastasis
granted -
US 11890281
SHP2 phosphatase inhibitors and methods of making and using the same
granted -
US 11891389
PGDH inhibitors and methods of making and using
granted -
US 11884748
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted